Optimising treatment of CF pulmonary exacerbation: a tough nut to crack

Affiliations

¹ Department of Pediatrics, University of Washington School of Medicine, Seattle, Washington, USA Cystic Fibrosis Foundation Therapeutics Development Network Coordinating Center, Seattle Children's Research Institute, Seattle, Washington, USA.
² Department of Pediatrics, University of Washington School of Medicine, Seattle, Washington, USA Cystic Fibrosis Foundation Therapeutics Development Network Coordinating Center, Seattle Children's Research Institute, Seattle, Washington, USA Division of Pulmonary and Critical Care Medicine, Department of Medicine, University of Washington School of Medicine Seattle, Seattle, Washington, USA.

Editorial

Sonya L Heltshe et al. Thorax. 2016 Feb.

. 2016 Feb;71(2):101-2.

doi: 10.1136/thoraxjnl-2015-208057.

¹ Department of Pediatrics, University of Washington School of Medicine, Seattle, Washington, USA Cystic Fibrosis Foundation Therapeutics Development Network Coordinating Center, Seattle Children's Research Institute, Seattle, Washington, USA.
² Department of Pediatrics, University of Washington School of Medicine, Seattle, Washington, USA Cystic Fibrosis Foundation Therapeutics Development Network Coordinating Center, Seattle Children's Research Institute, Seattle, Washington, USA Division of Pulmonary and Critical Care Medicine, Department of Medicine, University of Washington School of Medicine Seattle, Seattle, Washington, USA.

No abstract available

Keywords: Bronchiectasis; Cystic Fibrosis.

Comment on

A randomised trial of hypertonic saline during hospitalisation for exacerbation of cystic fibrosis.
Dentice RL, Elkins MR, Middleton PG, Bishop JR, Wark PA, Dorahy DJ, Harmer CJ, Hu H, Bye PT. Dentice RL, et al. Thorax. 2016 Feb;71(2):141-7. doi: 10.1136/thoraxjnl-2014-206716. Thorax. 2016. PMID: 26769016 Clinical Trial.

1. Britto MT, Kotagal UR, Hornung RW, et al. Impact of recent pulmonary exacerbations on quality of life in patients with cystic fibrosis. Chest. 2002;121(1):64–72. - PubMed
1. Habib AR, Manji J, Wilcox PG, et al. A systematic review of factors associated with health-related quality of life in adolescents and adults with cystic fibrosis. Annals of the American Thoracic Society. 2015;12(3):420–8. - PubMed
1. de Boer K, Vandemheen KL, Tullis E, et al. Exacerbation frequency and clinical outcomes in adult patients with cystic fibrosis. Thorax. 2011;66(8):680–5. - PubMed
1. Lieu TA, Ray GT, Farmer G, et al. The cost of medical care for patients with cystic fibrosis in a health maintenance organization. Pediatrics. 1999;103(6):e72. - PubMed
1. Liou TG, Adler FR, Fitzsimmons SC, et al. Predictive 5-year survivorship model of cystic fibrosis. American journal of epidemiology. 2001;153(4):345–52. - PMC - PubMed